NiKang Therapeutics
PrivateLast Round
Series C
May 26, 2021
Total Funding Raised
$270M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NiKang Therapeutics is a biotechnology company that discovers and develops innovative small molecule oncology medicines to address unmet medical needs through structure-based drug design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NiKang Therapeutics Comparables
Compare NiKang Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenzo Therapeutics | 78% | |
| Arcus Biosciences | 77% | |
| Novartis | 74% | |
NiKang Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 26, 2021 | ||||
| Series B | Sep 14, 2020 | ||||
| Seed | Dec 4, 2017 |
Key People
Founding team and executive leadership
NiKang Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C |
| Matrix | Series B, Series C |
| Surveyor Capital | Series C |
| Janus Henderson Group | Series C |
| RA Capital Management | Series C |
| Perceptive Advisors | Series C |
| Octagon Capital Advisors | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 96% MoM.
- May 20, 2026
Monthly visitors increased 207% MoM.
NiKang Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NiKang Therapeutics's valuation, stock price, and market status.